Table 3.
Event rates in drug exposure categories including methadone, hydromorphone, morphine and fentanyl. All opioid doses are adjusted and reported as their equivalent in oral methadone.
Methadone | Hydromorphone | |||||
---|---|---|---|---|---|---|
Days Exposed | % Days With Hypoglycemia | 95% CI | Days Exposed | % Days With Hypoglycemia | 95% CI | |
| ||||||
Oral 0-15 mg equivalent | 1033 | 3.9 | (2.9-5.2) | 1103 | 3.8 | (2.8-5.1) |
Oral 15-40 mg equivalent | 1883 | 4.2 | (3.4-5.2) | 72 | 4.2 | (1.4-11.5) |
Oral 40-80 mg equivalent | 1827 | 7.4 | (6.3-8.7) | 0 | ||
Oral > 80 equivalent | 1761 | 8.0 | (6.8-9.3) | 1 | 0.0 | (0.0-94.9) |
| ||||||
IV 0-15 mg equivalent | 314 | 5.7 | (3.7-8.9) | 1995 | 5.0 | (4.1-6.1) |
IV 15-40 mg equivalent | 498 | 5.6 | (3.9-8.0) | 562 | 5.2 | (3.6-7.3) |
IV 40-80 mg equivalent | 349 | 12.6 | (9.5-16.5) | 188 | 6.4 | (3.7-10.8) |
IV > 80 mg equivalent | 345 | 13.0 | (9.9-17.0) | 106 | 2.8 | (1.0-8.0) |
| ||||||
PCA | 542 | 16.4 | (13.5-19.8) | 2375 | 4.7 | (3.9-5.6) |
| ||||||
Morphine | Fentanyl | |||||
Days Exposed | % Days With Hypoglycemia | 95% CI | Days Exposed | % Days With Hypoglycemia | 95% CI | |
| ||||||
Oral 0-15 mg equivalent | 297 | 5.1 | (3.1-8.2) | 0 | ||
Oral 15-40 mg equivalent | 56 | 1.8 | (0.1-9.4) | 1 | 0.0 | (0.0-94.9) |
Oral 40-80 mg equivalent | 37 | 0.0 | (0.0-9.4) | 6 | 0.0 | (0.0-39.0) |
Oral > 80 equivalent | 43 | 0.0 | (0.0-8.2) | 27 | 3.7 | (0.2-18.3) |
| ||||||
IV 0-15 mg equivalent | 710 | 5.1 | (3.7-6.9) | 102 | 7.8 | (4.0-14.7) |
IV 15-40 mg equivalent | 33 | 18.2 | (8.6-34.4) | 227 | 4.8 | (2.7-8.5) |
IV 40-80 mg equivalent | 2 | 0.0 | (0.0-65.8) | 345 | 2.0 | (1.0-4.1) |
IV > 80 mg equivalent | 0 | 948 | 2.8 | (2.0-4.1) | ||
| ||||||
PCA | 575 | 5.2 | (3.7-7.4) | 2241 | 3.1 | (2.4-3.9) |
| ||||||
Transdermal | 1236 | 2.3 | (1.6-3.3) |